Previous close | 1.3400 |
Open | 1.3800 |
Bid | 1.3700 x 100 |
Ask | 1.4200 x 100 |
Day's range | 1.3500 - 1.4921 |
52-week range | 0.7900 - 4.3500 |
Volume | |
Avg. volume | 94,641 |
Market cap | 9.003M |
Beta (5Y monthly) | 1.20 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Inhibikase Therapeutics ( NASDAQ:IKT ) Full Year 2023 Results Key Financial Results Net loss: US$19.0m (loss widened by...
Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2023 Earnings Call Transcript March 28, 2024 Inhibikase Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, thank you for standing by. Greetings, and welcome to Inhibikase Therapeutics Fourth Quarter and […]
Q4 2023 Inhibikase Therapeutics Inc Earnings Call